(Q38991152)

8 September 2017

Association of MDR1 gene polymorphism (G2677T) with imatinib response in Egyptian chronic myeloid leukemia patients (English)

1 reference

8 September 2017

chronic myeloid leukemia

0 references

1 reference

Doaa M Elghannam

1

1 reference

8 September 2017

Lamia Ibrahim

2

1 reference

8 September 2017

Mohamed A Ebrahim

3

1 reference

8 September 2017

Emad Azmy

4

1 reference

8 September 2017

Hazem Hakem

5

1 reference

8 September 2017

language of work or name

1 reference

25 November 2013

1 reference

8 September 2017

1 reference

8 September 2017

19

1 reference

8 September 2017

3

1 reference

8 September 2017

123-128

1 reference

Chronic myelogenous leukemia (CML): resistance to tyrosine kinase inhibitors

8 September 2017

1 reference

https://api.crossref.org/works/10.1179%2F1607845413Y.0000000102

Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845413Y.0000000102

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845413Y.0000000102

MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845413Y.0000000102

Multidrug resistance in cancer: role of ATP-dependent transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845413Y.0000000102

A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845413Y.0000000102

A "silent" polymorphism in the MDR1 gene changes substrate specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845413Y.0000000102

Clinical significance of ABCB1 genotyping in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845413Y.0000000102

MDR1 genotype is associated with hepatic cytochrome P450 3A4 basal and induction phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845413Y.0000000102

Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845413Y.0000000102

Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845413Y.0000000102

Response definitions and European Leukemianet Management recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845413Y.0000000102

Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845413Y.0000000102

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845413Y.0000000102

P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845413Y.0000000102

Identification of functionally variant MDR1 alleles among European Americans and African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845413Y.0000000102

Clinical relevance of a pharmacogenetic approach using multiple candidate genes to predict response and resistance to imatinib therapy in chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845413Y.0000000102

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845413Y.0000000102

MDR1 Gene C1236T and C6+139T polymorphisms in the Russian population: associations with predisposition to lymphoproliferative diseases and drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845413Y.0000000102

The mdrl gene, responsible for multidrug-resistance, codes for P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845413Y.0000000102

Imatinib Disposition and ABCB1 (MDR1, P-Glycoprotein) Genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845413Y.0000000102

10.1179/1607845413Y.0000000102

21 January 2018

Identifiers

DOI

1 reference

8 September 2017

1 reference